ScholarIQanswers from OpenAlex

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease

PaperCitations, authors & open-access status

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is a paper indexed in ScholarIQ from OpenAlex.

How many citations does Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease have?

ScholarIQcitation count

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease has 435 citations in the OpenAlex counts ScholarIQ stores.

When was Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease published?

ScholarIQyear

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease has 2007 year in the ScholarIQ index.

What is the open-access status of Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

ScholarIQoa status

Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease has closed oa status in the ScholarIQ index.

What is the DOI of Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

ScholarIQdoi

The DOI for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is on the source record.

What is the PMID of Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

ScholarIQpmid

The PMID for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is on the source record.

What is the OpenAlex record for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease?

ScholarIQopenalex

The OpenAlex for Sustained, Long-Term Renal Stabilization After 54 Months of Agalsidase β Therapy in Patients with Fabry Disease is on the source record.

Related on ScholarIQ

470M+ articles · 14-day free trial